National Cancer Centre Singapore to test new ovarian cancer immunotherapy treatment

The National Cancer Centre Singapore (NCCS) has announced it is testing a new treatment for sufferers of ovarian cancer.

The treatment is said to potentially improve the quality of life for those in advanced or recurring stages of the disease.

See also: 

Japan's population ages at record pace

Singapore summit 2017 deals with Asian business opportunities 

Latest issue of Business Review Asia 

It is a form of immunotherapy, which harnesses the natural defences of the body to fight cancer. Unlike chemotherapy, it does not kill healthy cells in the body and therefore may have less side effects.

Immunotherapy is already used to treat some forms of cancer, such as lung and kidney, and it may soon be used as a second option for ovarian cancer patients if chemotherapy is seen to fail.

NCCS have stated that there is a new case of ovarian cancer diagnosed in Singapore “almost every day.” Between 2011-15, 1,797 new cases were diagnosed according to the Singapore Cancer Registry, and during that time 634 people died of the illness. This makes ovarian cancer the seventh-most common cause of cancer-related deaths in Singapore.

Currently, NCCS is just beginning the clinical trial. It hopes to test the safety and effectiveness of the treatments on 20 patients, who it is recruiting until the middle of next year. 


Featured Articles

Top 10 fastest growing companies in Asia-Pacific

From Singapore to South Korea, Hong Kong to India, and spanning fintech, food and energy – these 10 businesses are seeing their revenues rise, and fast

Top 10 best-performing Australian companies: mines to banks

Among Australia’s largest companies by market cap are the country’s Big Four banks, a tech startup that successfully scaled, and two firms with female CEOs

Top 10 richest Southeast Asia: how they made their fortunes

From Singapore’s paint tycoon to Malaysia’s sugar king, we round up the 10 richest people in Southeast Asia – and investigate how they made their billions

Will moonlighting ever become accepted practice in India?

Human Capital

New YouTube CEO Neal Mohan joins surge of Indian-origin CEOs

Leadership & Strategy

Ex Infosys President Ravi Kumar is the CEO Cognizant needs

Leadership & Strategy